Journal profile · Medicine-Psychiatry and Mental Health
Psychiatry and Clinical Psychopharmacology
ISSN 2475-0573 · eISSN 2475-0581 · Taylor and Francis Ltd. · United Kingdom
Psychiatry and Clinical Psychopharmacology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.33; fully open access; APC about USD 590; review about 30 weeks (community reports); 90 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Psychiatry and Clinical Psychopharmacology is published by Taylor and Francis Ltd. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Attention Deficit Hyperactivity Disorder, Child and Adolescent Psychosocial and Emotional Development and Tryptophan and brain disorders, together about 26.3% of its articles. Its main subfields are Psychiatry and Mental health. (generated from OpenAlex topic counts and CAS ranking data)
Psychiatry and Clinical Psychopharmacology aims to reach a national and international audience and will accept submissions from authors worldwide. It gives high priority to original studies of interest to clinicians and scientists in applied and basic neurosciences and related disciplines. Psychiatry and Clinical Psychopharmacology publishes high quality research targeted to specialists, residents and scientists in psychiatry, psychology, neurology, pharmacology, molecular biology, genetics, physiology, neurochemistry, and related sciences.
Source: LetPub
Research area (LetPub): Medicine-Psychiatry and Mental Health
Main research topics OpenAlex counts of recent articles; shares are approximate
- Attention Deficit Hyperactivity DisorderMedicine9.8%
- Child and Adolescent Psychosocial and Emotional DevelopmentPsychology8.9%
- Tryptophan and brain disordersNeuroscience7.7%
- Bipolar Disorder and TreatmentMedicine7.6%
- Schizophrenia research and treatmentMedicine7.2%
- Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychology5.3%
- Treatment of Major DepressionMedicine4.9%
- Obsessive-Compulsive Spectrum DisordersPsychology4.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
| Minor | Psychiatry | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
| Minor | Psychiatry | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
| Minor | Psychiatry | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.33LetPub ·
- CiteScore 2026-06
- 1.2LetPub ·
- SJR 2026-06
- 0.42LetPub ·
- SNIP 2026-06
- 0.45LetPub ·
- h-index
- 29OpenAlex ·
- i10-index
- 117OpenAlex ·
- 2-year mean citedness
- 1.81OpenAlex ·
- Self-citation rate
- 12.5%LetPub ·
- Share of gold OA articles
- 97.4%LetPub ·
Volume
- Articles per year
- 64LetPub ·
Articles by year OpenAlex count · 702 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 24 | 24 | 1 |
| 2025 | 90 | 90 | 100 |
| 2024 | 48 | 48 | 193 |
| 2023 | 55 | 55 | 159 |
| 2022 | 40 | 40 | 142 |
| 2021 | 62 | 62 | 327 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 30 weeksLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 590 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Taylor and Francis Ltd.
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 2475-0573
- Electronic ISSN
- 2475-0581
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Psychiatry and Clinical Psychopharmacology
What CAS zone is Psychiatry and Clinical Psychopharmacology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Psychiatry and Clinical Psychopharmacology is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy / Psychiatry. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Psychiatry and Clinical Psychopharmacology?
The latest impact factor listed by LetPub is 1.33; CiteScore 1.2, h-index 29.
How long does peer review take at Psychiatry and Clinical Psychopharmacology?
Authors report an average review time of about 30 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Psychiatry and Clinical Psychopharmacology?
According to LetPub and DOAJ records, Psychiatry and Clinical Psychopharmacology is indexed in SCIE, Scopus and DOAJ.
Is Psychiatry and Clinical Psychopharmacology open access, and what is the APC?
Psychiatry and Clinical Psychopharmacology is a fully open-access journal. APC about USD 590.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .